LANZHOU UNIVERSITY TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED's US Patent application for "GLUCAGON RECEPTOR ANTAGONIST AND USE THEREOF" is in published phase now

Press/Media

Period10 Apr 2023

Media coverage

1

Media coverage

  • TitleLANZHOU UNIVERSITY TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED's US Patent application for "GLUCAGON RECEPTOR ANTAGONIST AND USE THEREOF" is in published phase now
    Media name/outletImpact Financial News
    Country/TerritoryUnited Kingdom
    Date10/04/23
    PersonsHUANXIANG LIU
View all 1
View less